Celsius Holdings, Inc. Forecasted to Earn Q2 2024 Earnings of $0.24 Per Share (NASDAQ:CELH)

Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) - Investment analysts at Roth Capital decreased their Q2 2024 EPS estimates for Celsius in a report issued on Wednesday, May 8th. Roth Capital analyst S. Mcgowan now anticipates that the company will post earnings of $0.24 per share for the quarter, down from their previous forecast of $0.27. The consensus estimate for Celsius' current full-year earnings is $1.09 per share. Roth Capital also issued estimates for Celsius' Q3 2024 earnings at $0.29 EPS, Q1 2025 earnings at $0.27 EPS, Q2 2025 earnings at $0.35 EPS, Q3 2025 earnings at $0.42 EPS, Q4 2025 earnings at $0.37 EPS and FY2025 earnings at $1.41 EPS.

Celsius (NASDAQ:CELH - Get Free Report) last released its earnings results on Tuesday, May 7th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.20 by $0.07. Celsius had a return on equity of 131.58% and a net margin of 17.21%. The business had revenue of $355.70 million for the quarter, compared to the consensus estimate of $390.37 million. During the same period in the previous year, the company posted $0.13 earnings per share. The company's revenue for the quarter was up 36.9% compared to the same quarter last year.

CELH has been the subject of several other reports. Bank of America cut shares of Celsius from a "buy" rating to a "neutral" rating and set a $65.00 target price for the company. in a report on Friday, January 19th. Morgan Stanley restated an "equal weight" rating and issued a $75.00 price objective on shares of Celsius in a report on Wednesday, March 27th. Wedbush reiterated an "outperform" rating and set a $100.00 target price on shares of Celsius in a research note on Friday, May 3rd. Maxim Group lifted their target price on Celsius from $100.00 to $110.00 and gave the stock a "buy" rating in a report on Monday, April 1st. Finally, Roth Mkm increased their price objective on Celsius from $90.00 to $105.00 and gave the company a "buy" rating in a research report on Thursday, March 14th. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, Celsius presently has a consensus rating of "Moderate Buy" and a consensus price target of $84.95.

Celsius Stock Performance

Shares of CELH traded up $4.94 during trading hours on Thursday, hitting $82.07. The company had a trading volume of 8,865,591 shares, compared to its average volume of 4,838,855. Celsius has a 52-week low of $39.50 and a 52-week high of $99.62. The firm has a fifty day moving average price of $81.42 and a 200-day moving average price of $65.97. The stock has a market capitalization of $18.96 billion, a price-to-earnings ratio of 110.01, a P/E/G ratio of 2.22 and a beta of 1.93.

Insider Transactions at Celsius

In related news, major shareholder Dean Desantis sold 100,000 shares of the stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $95.75, for a total value of $9,575,000.00. Following the completion of the sale, the insider now directly owns 219,257 shares of the company's stock, valued at approximately $20,993,857.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, major shareholder Dean Desantis sold 100,000 shares of the company's stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $95.75, for a total value of $9,575,000.00. Following the completion of the transaction, the insider now owns 219,257 shares of the company's stock, valued at approximately $20,993,857.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Nicholas Castaldo sold 165,000 shares of the firm's stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $83.33, for a total value of $13,749,450.00. Following the sale, the director now directly owns 352,864 shares in the company, valued at $29,404,157.12. The disclosure for this sale can be found here. Insiders have sold 2,045,196 shares of company stock valued at $131,499,404 over the last quarter. 2.20% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Celsius

Several institutional investors and hedge funds have recently modified their holdings of CELH. Cary Street Partners Investment Advisory LLC grew its stake in Celsius by 1,350.0% during the third quarter. Cary Street Partners Investment Advisory LLC now owns 145 shares of the company's stock valued at $25,000 after acquiring an additional 135 shares in the last quarter. Contravisory Investment Management Inc. bought a new position in Celsius during the fourth quarter valued at approximately $25,000. Transcendent Capital Group LLC purchased a new stake in shares of Celsius during the 4th quarter worth approximately $25,000. FinTrust Capital Advisors LLC purchased a new position in shares of Celsius in the first quarter valued at $25,000. Finally, Tidemark LLC bought a new stake in Celsius in the fourth quarter worth $29,000. Institutional investors own 60.95% of the company's stock.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.